451 related articles for article (PubMed ID: 9006333)
1. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
3. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
[TBL] [Abstract][Full Text] [Related]
4. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
5. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.
Ozçelik H; Mousses S; Andrulis IL
Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p53 induced tumor suppressor p21waf1/cip1 in ovarian carcinomas: correlation with p53 and Ki-67 immunohistochemistry.
Werness BA; Jobe JS; DiCioccio RA; Piver MS
Int J Gynecol Pathol; 1997 Apr; 16(2):149-55. PubMed ID: 9100069
[TBL] [Abstract][Full Text] [Related]
8. Analysis of p21WAF1/CIP1 in primary bladder tumors.
Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
[TBL] [Abstract][Full Text] [Related]
10. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].
Jiang M; Shao Z; Wu J
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):181-4. PubMed ID: 10921001
[TBL] [Abstract][Full Text] [Related]
11. p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.
Werness BA; Wang HQ; Chance J; Goldstein DJ
Mod Pathol; 1997 Jun; 10(6):578-84. PubMed ID: 9195575
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao X; Chen YQ; Wu N; Grignon DJ; Sakr W; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1395-8. PubMed ID: 7478562
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.
Balbín M; Hannon GJ; Pendás AM; Ferrando AA; Vizoso F; Fueyo A; López-Otín C
J Biol Chem; 1996 Jun; 271(26):15782-6. PubMed ID: 8663132
[TBL] [Abstract][Full Text] [Related]
14. Novel p21WAF1/CIP1 mutations in superficial and invasive transitional cell carcinomas.
Malkowicz SB; Tomaszewski JE; Linnenbach AJ; Cangiano TA; Maruta Y; McGarvey TW
Oncogene; 1996 Nov; 13(9):1831-7. PubMed ID: 8934528
[TBL] [Abstract][Full Text] [Related]
15. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
16. WAF1 genotype and endometrial cancer susceptibility.
Hachiya T; Kuriaki Y; Ueoka Y; Nishida J; Kato K; Wake N
Gynecol Oncol; 1999 Feb; 72(2):187-92. PubMed ID: 10021299
[TBL] [Abstract][Full Text] [Related]
17. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene.
Facher EA; Becich MJ; Deka A; Law JC
Cancer; 1997 Jun; 79(12):2424-9. PubMed ID: 9191533
[TBL] [Abstract][Full Text] [Related]
18. Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.
McKenzie KE; Siva A; Maier S; Runnebaum IB; Seshadri R; Sukumar S
Clin Cancer Res; 1997 Sep; 3(9):1669-73. PubMed ID: 9815858
[TBL] [Abstract][Full Text] [Related]
19. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1.
Chedid M; Michieli P; Lengel C; Huppi K; Givol D
Oncogene; 1994 Oct; 9(10):3021-4. PubMed ID: 8084608
[TBL] [Abstract][Full Text] [Related]
20. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
